AI standards launched to help tackle problem of overhyped studies

New guidelines aimed at ensuring AI research is of same quality as that in other fields

The first international standards for the design and reporting of clinical trials involving artificial intelligence have been announced in a move experts hope will tackle the issue of overhyped studies and prevent harm to patients.

While the possibility that AI could revolutionise healthcare has fuelled excitement, in particular around screening and diagnosis, researchers have previously warned that the field is strewn with poor-quality research.